Takeda Chemical Industries Ltd.: Lessons from a Japanese Pharma Major
ICMR HOME | Case Studies Collection
Business Strategy Case Studies
Takeda owned/produced four highly successful drugs [Actos (for treating diabetes), Lansoprazole (for treating ulcers), Lupron Depot (for treating prostate cancer) and Cendesartan (for hypertension)]. In addition, the company had as many important new drugs in the pipeline as some of the world's biggest pharmaceutical companies. Keeping in view the growth oriented initiatives taken by the company, industry observers stated that Takeda was all set to emerge as a major global player in the near future. It already was one of the fastest growing Japanese pharmaceutical companies, a fact amply reflected in its strong financial performance over the years. In 2002, Takeda posted consolidated profits of $8.9 billion. It was the only Japanese company that had posted record profits and sales for 10 consecutive years (Refer Exhibit I for a 10-year summary of Takeda's key financial data).
Chobei Takeda IV formed co-operative unions in Yokohama for purchasing foreign medicines and began transactions with foreign trading companies.
Case Studies Links:-
Short Case Studies,
Simplified Case Studies.
Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.
Business Reports Link:- Business Reports.
Books:- Textbooks, Workbooks, Case Study Volumes.
|Business Environment||Business Ethics||Business Reports||Business Strategy|
|Corporate Governance||Economics||Enterprise Risk Management||Finance|
|HRM||Innovation||Insurance||IT and Systems|
|Leadership and Entrepreneurship||Marketing||Miscellaneous||Operations|
|Project Management||Short Case Studies||Cases in other Languages||Free Case Studies|